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Abstract 
Background:  Translational and applied health research, and the workforce needed to 
deliver it, have grown substantially in the last 10 years and this growth is likely to continue.  
However, there are few good empirical studies of the workforce and only limited evidence on 
which to base future policy and practice. 
Aim:  To provide a better understanding of the workforce that delivers translational and 
applied health research by exploring who delivers studies, what types of studies are delivered 
and what delivering them entails and whether this varies across employment contexts. 
Methods:  A link to an on-line questionnaire was sent to 280 non-medical researchers in 
England funded by National Institute for Health Research to deliver translational and applied 
health research; 168 (60%) responded.  Responses were analysed quantitatively.   
Findings:  Participants were from 11 occupational groups, with nurses (77%) the most 
common. Most (82%) had worked on clinical trials and almost as many (73%) on 
observational studies.  A fifth had conducted studies outside hospital settings.  Participants 
recruited from Community sites more often reported taking a medical history (p=0.022) and 
carrying out initial assessments (p=0.028) and less often reported managing other staff 
(p=0.036).  Those recruited through the University Hospital more often reported contributing 
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to development of new studies (p=.000); to research governance (p =0.001) and protocols 
(p=0.000); and to writing publications (p=0.005).  
Discussion:  There is greater diversity in the workforce than previously identified, more 
variation in types of studies delivered and a wider range of settings. Responsibilities vary 
across employment contexts.  
Conclusions:  This diversity needs to be acknowledged in educational, training and career 
planning to sustain capacity for delivering translational and applied health research in the 
future.   
 
 
Keywords: Labor Force; Research Personnel; Surveys and Questionnaires; Clinical trials 
nurse; Research coordinator; Research nurse 
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Summary of Relevance 
Problem:  Little is known about the workforce that delivers clinical research, where they 
work and what they do.  
What is Already Known:   Research nurses are fundament to the delivery of clinical trials 
in hospitals. The recent growth in clinical research has led to an increase in demand for a 
workforce to deliver more studies.  
What this paper adds:   The workforce is more diverse, and the types of studies and 
settings in which they are delivered are more varied than previously reported.  The 
institutional context in which research nurses work offer varying degrees of challenge and 
scope for developing further skills and experience. 
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Introduction 
In the UK, translational and applied health research has grown substantially following the 
publication in 2006 of the Department of Health’s research strategy, Best Research for Best 
Health.  This document identified health research as playing ‘a key role in the knowledge 
economy of our country through its contribution to international competitiveness and 
economic growth’ and as providing a centrepiece for the UK government’s determination ‘to 
raise the level of research and development (R&D).’ (Research and Development 
Directorate, 2006: 1).  Later in 2006 the National Institute for Health Research (NIHR) was 
established to provide the framework through which this strategy could be implemented.  In 
addition to funding high quality peer-reviewed research through its Research Programmes, 
NIHR supports translational and applied health research through an extensive research 
infrastructure which provides practical assistance in the design and conduct of commercial 
and non-commercial studies, a range of research training programmes which build research 
capability and capacity, and research information systems which ensure integration across 
the National Health Service (NHS) and partner organisations (http://www.nihr.ac.uk/about/ ).  
This extensive and multi-layered support has created a context in which translational and 
applied health research has thrived.  
 
As in other countries (eg Bell, 2009; Rickard & Roberts, 2008; Wilkes, Jackson, Miranda, & 
Watson, 2012), the growth of translational and applied health research in the UK has seen a 
corresponding growth in the workforce needed to deliver it.  ‘Translational research’ aims to 
turn the discoveries of basic science into new treatments, technologies, diagnostics and other 
interventions which will provide benefit to patients.  It involves, for example, pre-clinical and 
early phase clinical trials and proof-of-concept studies in humans.  ‘Applied health research’ 
addresses specific clinical, health services, public health or policy questions.  It includes, for 
example, epidemiological studies, case series and case-control studies, cohort studies, later 
phase clinical trials, outcomes research and health services research (Rubio, Schoenbaum, 
Lee et al, 2010; University of California San Francisco, n.d.). ‘Delivering’ (or ‘supporting’) a 
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study, whether translational or applied health research, entails implementing the study 
protocol on behalf of the Chief and/or Principal Investigators and their collaborators so that 
the study can be completed successfully and on time.  Key features include recruiting the 
minimum number of participants agreed for the study and collecting and entering research 
data, all in keeping with Good Clinical Practice (https://www.crn.nihr.ac.uk/can-help/funders-
academics/ ).  ‘Implementing’ results is also an important aspect of translational and applied 
health research but the time taken to establish study results and to test their robustness 
through publications and peer review means that putting findings into practice is largely 
outside the scope of research nurses. 
 
The NIHR has been a major funder of those who deliver research in England:  in 2015 the 
NIHR Clinical Research Network alone provided funding for almost 10,000 posts (J. 
Patterson, personal communication,13 January 2016) while many more posts were funded 
through NIHR Biomedical Research Centres, NIHR Clinical Research Facilities and other 
NIHR infrastructure organisations (http://www.nihr.ac.uk/about/nihr-infrastructure.htm ).  The 
continued growth of translational and applied health research, reinforced more recently by the 
UK government’s Plan for Growth (Department for Business, Innovation and Skills, 2011), is 
likely to create a continuing demand for this workforce in order to deliver studies ‘to time and 
target’ in both the commercial and non-commercial sectors (Spilsbury, 2008).  However, 
there are few good empirical studies of this workforce and only limited understanding of what 
they do. 
 
Literature Review  
Nurses have been by far the largest group employed to deliver research, although studies 
have reported other health professionals as also employed in this role (Eastwood, Roberts, 
Williams, & Rickard, 2012; Rickard, Roberts, Foote, & McGrail, 2006; Rickard et al, 2011; 
Scott, White, & Roydhouse, 2013; Wilkes et al, 2012).  There is now a substantial body of 
literature on research nurses, also commonly referred to as clinical trials nurses, clinical 
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research nurses or research co-ordinators (eg Barthow, Jones, Macdonald et al, 2015; 
Castro, Bevans, Miller-Davis et al, 2011; Hill & McArthur, 2006; Rickard et al, 2011; Spilsbury 
Petherick, Cullum et al 2008).  While this literature has provided valuable information on the 
workforce delivering health research, it has a number of limitations.  Much is comprised of 
commentaries rather than empirical studies (eg Bird & Kirshbaum, 2005; Gibbs and Lowton, 
2012; Gordon, 2008; Hastings, Fisher & McCabe, 2012; Ledger, Pulfrey, & Luke, 2008; 
Stephens-Lloyd, 2004) and most of the empirical studies have focused on those who work on 
clinical trials (eg Spilsbury et al, 2008; Wilkes et al, 2012; Yanagawa, Akaishi, Miyamoto et al, 
2008) in a hospital setting (eg Hill & MacArthur, 2006; Rickard et al, 2011; Roberts, 
Eastwood, Raunow, et al, 2011) or on research within a single specialist area (eg Catania, 
Poire, Bernardi et al 2012; Eastwood et al, 2012; Nagel, Gender, & Bonner 2010; Rickard et 
al, 2006; Roberts et al, 2011).  Translational and applied health research, however, 
encompasses a much wider range of studies than clinical trials and studies may be 
undertaken in settings other than hospitals.  In addition, as the number of studies continues 
to grow, the demand for research nurses may exceed the supply available and it may 
become more difficult to recruit experienced nurses to deliver research (Pharmaceuticals and 
Biotechnology Branch, 2006). Relatively little is known about these developments and their 
implications for the composition of the future research workforce and the nature of their roles 
and responsibilities.  In addition, there are significant methodological limitations to the 
research nurse literature, with most studies based on small scale convenience samples that 
have been recruited through a single organisation (eg Catania et al 2012; Nagel et al, 2010; 
Rickard et al, 2006; Spilsbury et al, 2008), or through snowball sampling (eg Eastwood et al, 
2012; Rickard et al, 2011; Wilkes et al 2012).   
 
Clearly, only limited evidence is available on which to base future policy and practice in the 
delivery of health research.  This paper presents a study intended to provide a better 
understanding of the workforce that delivers translational and applied health research.  It 
addresses three main questions:  who delivers studies; what types of studies are delivered; 
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and what does delivering them entail?  In addition, it explores whether their responsibilities 
vary across the different contexts in which they are employed.   
 
 
Study design, ethics and participants 
Study Design 
The study was designed as a cross-sectional, mixed methods study comprising a 
questionnaire and focus groups. However, topics discussed in the focus groups were not 
relevant to the questions addressed in this paper and are not presented here. 
 
Ethics and Approvals 
The research protocol was reviewed and approved by the University Research Ethics 
Committee of Oxford Brookes University (UREC Registration Number 130703). NHS Trust 
approvals were sought and received from their R&D Department. The work described in this 
paper was carried out in accordance with the Code of Ethics of the World Medical 
Association’s Declaration of Helsinki (World Medical Association, 2001). 
 
Participants 
The population of interest was defined by the following criteria: 
Inclusion criteria:  Non-medical researchers who deliver (rather than lead) translational and 
applied health research and have direct contact with research participants; funded by an 
NIHR infrastructure organisation; and employed by a NHS Trust, Primary Care practice or, in 
the case of a Biomedical Research Centre/Unit only, a University. 
Exclusion criteria:  Those who lead (rather than deliver) research (eg Chief or Principal 
Investigators); those who do not have direct contact with research participants (eg Clinical 
Trials Unit Directors) 
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The employing organisations included the following:  the University Hospital, a large, 
research active hospital on four sites incorporating a major research intensive Medical School 
as well as a Biomedical Research Centre and Biomedical Research Unit and providing a 
wide range of secondary and tertiary hospital services; four Other hospitals in urban centres 
across the area, providing a range of acute and follow-up hospital services for their 
communities, commonly on several sites; two Community healthcare providers delivering 
care for mental and physical health from bases in the community, hospitals, specialist clinics 
and people’s homes, one of which incorporated a Clinical Research Facility; and 11 GP 
Practices which were largely small independent businesses, funded by the NHS to provide 
primary care to their practice population of registered patients. 
 
The NIHR infrastructure organisations (http://www.nihr.ac.uk/about/nihr-infrastructure.htm) 
included the following:  a Biomedical Research Centre (BRC) which is a partnership between 
the University Hospital and University, funded to conduct translational research; a Biomedical 
Research Unit (BRU), similar to a BRC but with a focus on a specific therapeutic area of 
disease; a Clinical Research Facility (CRF), which is a partnership between one of the 
Community sites and University, also funded to facilitate translational research; two generic 
Clinical Research Networks (CRN), covering hospital, primary care and community settings, 
and three Topic Specific Research Networks, covering cancer, dementias and 
neurodegeneration, and diabetes, which deliver studies adopted onto the NIHR Portfolio (ie 
high quality studies that are of clear value to patients or the NHS; funded through a nationally 
competitive, peer-reviewed process; and reviewed by a Clinical Research Network or a 
Network Industry Adoption Panel (https://www.crn.nihr.ac.uk/can-help/funders-academics/). 
 
Those identified through the BRC and BRU were employed to work on studies for which the 
BRC or BRU had received funding directly from NIHR.  Those identified through the Clinical 
Research Networks were funded to support studies adopted onto the NIHR Portfolio along 
9 
 
the last three stages of the ‘Research Delivery Pathway’, including supporting the set-up and 
start-up of studies, study recruitment and follow-up and study closure.  
 
 
Methods 
(i) Recruitment of participants 
All those who met these criteria were contacted between June and October 2013.  To meet 
data protection requirements, the participating infrastructure organisations identified those 
eligible and sent their names directly to the relevant Research and Development (R&D) 
Manager in their employing Trust, or to the Operations Manager at the BRC and BRU or to 
their Research Network manager, as appropriate.  At the same time, MB sent each manager 
an email invitation with a weblink to the on-line questionnaire specific to their organisation 
and a participant information sheet as an attachment, for them to forward to the list of 
individuals identified by the NIHR infrastructure organisation.  Two reminder emails were sent 
out to all those initially contacted. 
 
(Iii) Data Collection 
The questionnaire was developed by MB, an experienced social science researcher, on the 
basis of a literature review and an earlier small scale study of research nurses.  A weblink to 
the draft questionnaire was sent to three research nurses, an occupational therapist, and two 
physiotherapists in another area of England as well as two senior research nurses and three 
NIHR Clinical Research Network managers.  Eight individuals completed the questionnaire 
and provided written feedback; the questionnaire was revised to take account of their 
comments.  Questions either asked participants to write in their response, offered options for 
them to choose from or provided a list of items where they could choose all that applied.  
Most included ‘other’ as an option and where further information was specified the response 
was recoded to one of the options provided or a new response option added.  Those who 
indicated ‘not applicable’ were excluded from the analysis.  Questionnaires were completed 
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on-line between June and December 2013; completion was taken as indicating consent to 
take part in the study. 
 
(iii) Data Analysis 
Data from the on-line questionnaires were downloaded into IBM SPSS (Version 19) for 
analysis.  Descriptive statistics were produced using totals and percentage for categorical 
variables and mean, standard deviation and range for interval variables.  To examine 
associations between categorical variables, a Pearson chi square was first calculated as a 
measure of statistical significance, with p values of 0.05 or less regarded as significant.  
Where a statistically significant difference was found, Cramer’s V was used to determine 
strength of association between the variables.  An association of between .20 and .25 was 
considered a moderate association, between .25 and .30 a moderately strong and above .30 
a strong association.  Missing data were excluded when examining associations. 
 
 
Findings 
 
Completed questionnaires were received from 168 of the 280 individuals invited to take part, 
a response rate of 60%.   
 
As the number of participants from each of the 14 recruiting organisations was quite small, 
they were combined into three larger groups according to their employment context:  
University Hospital (109, 65%), Other hospitals (36, 21%), and Community (including primary 
care) (23, 14%).  The response rate was higher for those recruited through the University 
Hospital (109/165, 66%) compared with those recruited through Other hospitals (36/74, 49%) 
and the Community (23/41, 56%). 
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(i)  Who delivers translational and applied health research?  
The socio-demographic characteristics of the sample are shown in Table 1.  All but 7 
participants were female, more than 80% were between the ages of 25 and 54, and three 
quarters had qualifications at Bachelor’s degree level or above, including 6 who had a PhD or 
Professional Doctorate.   
 
--- Table 1 about here --- 
 
Nurses (121, 77%) were the largest professional group; the remainder comprised individuals 
from 10 other backgrounds.  A higher proportion of those recruited through the Community 
came from backgrounds other than nursing while those recruited through the University 
Hospital included the greatest variety of professional backgrounds.  
 
The employment characteristics of the sample are shown in Table 2.  Two thirds of 
participants were employed solely in research posts.  However, this proportion is significantly 
higher amongst those recruited through the University Hospital compared to those recruited 
through Other hospitals and Community sites (Pearson chi-square = 15.951, 2 df, p = 0.000, 
Cramer’s V = 0.309).  The majority were employed full-time.  
 
--- Table 2 about here --- 
 
A quarter of participants had worked in their current post for less than a year and a further 
third for only 1 to 2 years.  The total number of years worked as a researcher (including all 
posts) ranged from 0 to 23 years (mean 4.7, standard deviation 4.7).   
 
(ii)  What types of studies are ‘delivered’ and in what context?    
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Table 3 shows the characteristics of the studies on which the participants worked.  Although 
all studies had been funded by the NIHR and/or adopted onto the NIHR portfolio, the 
potential diversity amongst them was nonetheless considerable.   
 
--- Table 3 about here --- 
 
Types of studies  
Almost two thirds (102/168, 61%) of participants had worked on a clinical trial involving an 
investigational medicinal product (CTIMP), with remarkably similar proportions across the 
three recruitment sites.  Most had worked on Phase 2 trials (43/102, 42%) designed to 
assess how well the drug works and to continue safety assessments begun in Phase 1 trials, 
and/or on Phase 3 trials (70/102, 69%) designed to affirm the safety and efficacy of the drug 
and assess its clinical effectiveness in relation to the current gold standard.  A quarter had 
worked on post-marketing Phase 4 trials (25/102, 25%).  Only 10/102 (10%) had worked on 
Phase 1 trials, which look at optimum dose levesl and side effects, while a similar proportion 
(12/102, 12%) were uncertain of the type of trial they had worked on.   
 
More than half (98/168, 58%) the participants had worked on other types of clinical trials or 
intervention studies, most commonly studies involving a medical device (46/98, 47%), a 
surgical intervention (31/98, 31%) or an exercise or physical therapy (25/98, 26%).  Less than 
a fifth (18/98, 18%) had worked on psychological or behaviour change interventions, though 
this rose to half (9/18, 50%) amongst those recruited through the Community sites.   
 
Overall, 132/168 (79%) had worked on some type of clinical trial or intervention study. 
 
More than two thirds (118/168, 70%) had worked on observational studies, including 
genetic/genomic (61/118, 52%), bio-bank, (58/118,49%) and/or registry or database studies 
(57/118, 48%).  Nearly half the participants (53/118, 45%) had worked on questionnaire 
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based studies with a significantly higher proportion (11/13, 85%) of those recruited from 
Community compared to University Hospital (26/79, 33%) or Other hospitals (16/26, 62%) 
sites (x2 = 8.583, 2 df, p=0.014, Cramers V = .226).   
 
The majority of those who worked on a CTIMP (61/102, 69%) had also worked on studies 
involving another type of intervention and three quarters (77/102, 75%) had also worked on 
observational studies. 
 
Study settings 
Hospitals were the most common setting for research studies, though this varied from almost 
all those recruited through the University Hospital to a quarter of those recruited through 
Community sites.  About a fifth of participants (31/168, 18%) carried out studies in either 
General practice or other community settings:  this varied from about one in eight of those 
recruited through the University Hospital and Other hospitals to three in four of those 
recruited through Community sites.   
 
Study sponsor   
More than three quarters of participants had worked on studies that were sponsored by a 
University, almost two thirds by an NHS Trust and half by a commercial organisation.   
 
Number of studies   
Most participants had worked on multiple studies in the previous 12 months:  less than one in 
ten had worked on just one study while one in five had worked on more than 10 studies 
(mean 7.9, standard deviation 7.26, range 40).   
 
(iii)  What does ‘delivering’ translational and applied health research entail? 
Main duties and responsibilities  
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A list of duties and responsibilities was drawn up based initially on job descriptions and a 
review of the literature on research nurses, and revised following piloting of the questionnaire.  
Participants were asked to indicate which had been their main duties in delivering research 
studies over the last 12 months.  These responsibilities were then divided into three groups, 
according to the proportion of participants who had indicated that they had been among their 
main duties:  those identified by 75% or more were labelled ‘core responsibilities’, those 
identified by 50% to 74% were labelled ‘common responsibilities’ and those identified by less 
than 50% were labelled ‘specialist responsibilities’.  Responsibilities identified by less than 
10% of participants were excluded. 
 
--- Table 4 about here --- 
 
Responses are shown in Table 4.  Core responsibilities entailed liaising with clinical staff; 
identifying, recruiting and consenting participants; and collecting and entering clinical data.  
Interestingly, obtaining written informed consent was reported by a significantly smaller 
proportion of those recruited through the University Hospital (Cramer’s V = .199, p=0.043).   
 
Common responsibilities included assessing patients and providing and/or co-ordinating care; 
further aspects of collecting and managing research data; and contributing to research 
governance.  A significantly larger proportion of those recruited through Community sites 
reported carrying out initial assessments and physical examination (Cramer’s V = .211, 
p=0.028) while a significantly higher proportion of those recruited through the University 
Hospital reported contributing to research governance (Cramer’s V = .302, p= 0.001). 
 
Specialist responsibilities were diverse. They included liaising with external organisations, 
reported by just under half of participants across the recruitment sites as well as processing 
biological samples, reported by about a third of participants across the recruitment sites.  By 
contrast, a significantly higher proportion of those recruited through the University Hospital 
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reported contributing to or amending protocols (Cramer’s V = .316, p=0.000) as among their 
responsibilities while of those recruited through the Community a significantly higher 
proportion reported taking a medical history (Cramer’s V = .218, p=0.022) and a significantly 
lower proportion reported managing other staff (Cramer’s V = .204, p=0.036). 
 
Responsibilities outside the Research Delivery Pathway  
A minority of participants reported responsibilities outside the Research Delivery Pathway, 
including data analysis, dissemination activities and development of new studies.  Over a 
third of participants reported presenting posters or giving talks on their studies, with similar 
proportions across the recruitment sites, and more than a quarter reported contributing to 
data analysis.  Less than a fifth reported contributing to publications, with a significantly 
higher proportion of those recruited from the University Hospital doing so (Cramer’s V = .259, 
p=0.005).  A quarter reported contributing to the development of new studies, almost all 
recruited through the University Hospital (Cramer’s V = .378, p=0.000).   
 
 
Discussion 
Research nurses and others who ‘deliver’ studies make a significant contribution to the 
success of research, providing ‘care work’ while implementing study protocols on behalf of 
the (usually medical) lead researchers.  In the UK, this workforce has grown substantially 
over the last decade in the context of substantial government funding (Department for 
Business, Innovation and Skills, 2011), an explicit commitment to research in the NHS 
constitution (Department of Health, 20015) and the support of NIHR infrastructure 
organisations (http://www.nihr.ac.uk/about/).  This paper has explored three key questions 
regarding this workforce.  The findings are discussed below in relation to previous studies 
and their implications for the future of this workforce are considered. 
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(i) Who delivers translational and applied health research?   
As in previous studies, almost all those in this study were female, most were between the 
ages of 35 and 54 and the great majority were nurses (Eastwood et al, 2012; Rickard et al, 
2006; Rickard et al, 2011; Roberts et al, 2011; Wilkes et al, 2012).  However, this study has 
documented greater diversity in the workforce than earlier studies.  Previous studies have 
reported individuals from other backgrounds as employed in delivering research (Rickard et 
al, 2006, Rickard et al, 2011; Wilkes et al 2012), but with one exception (Eastwood et al,  
2012), numbers have been small.  In this study, almost a quarter were from backgrounds 
other than nursing and of those recruited through community sites, this rose to more than 
half.  The reasons for this greater diversity are not clear, but could reflect both difficulties in 
recruiting nurses to research posts as well as a recognition that, for some studies, individuals 
from different backgrounds may bring appropriate skills (Rickard and Roberts, 2008).  
Whatever the case, in the context of the growing shortage of nurses generally (Centre for 
Workforce Intelligence, 2013; Imison, 2015) it is likely that recruiting nurses to, and retaining 
them in, research posts will become more challenging in the future.   
 
The longer term implications of the widening range of professional expertise among those 
who deliver research are also unclear.  While it may be appropriate in order to meet the 
demands for a workforce to deliver a growing body of research, it could also mark the start of 
a process of progressive differentiation among types of applied health research, for example 
with nurses specialising in interventional studies where clinical care and patient safety are of 
greatest concern, while observational and other studies are delivered by those with other 
relevant qualifications.  If this is the case, it will be important to ensure that all those who 
deliver research prioritise the principles of Good Clinical Practice and that they put the rights, 
safety and wellbeing of participants are at the heart of their relationship.  In some cases, for 
example Clinical Trials of an Investigational Medicinal Products (CTIMPs), it will be essential 
to employ a trained nurse so that research participants are appropriately safeguarded.  
Where this is not the case, it will be important to set out competency frameworks, to provide 
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appropriate training and supervision and to develop professional identities for those recruited 
from other backgrounds.   
 
(ii) What types of studies are delivered and in what context?   
In contrast to much of the earlier literature where the assumption, implicit or explicit, has been 
that research nurses conduct clinical trials in hospitals (eg Catania et al, 2012; Gordon, 2008; 
Raja-Jones, 2002; Spilsbury et al, 2008; Stephens-Lloyd, 2004), in this study nearly three 
quarters of participants had engaged in observational studies and a fifth carried out studies 
based in the community.  Almost half had worked on both clinical trials and observational 
studies, a finding consistent with recent studies (Rickard et al, 2006; Rickard et al 2011; 
Roberts, et al, 2011).  Furthermore, the majority worked on more than five studies in the 
same year and one in ten on more than 15 studies.  While this is also consistent with 
previous research (Eastwood et al, 2012; and Roberts et al, 2011) it suggests a demanding 
workload and further research is needed on how such workloads are determined, 
experienced and managed.   
 
(iii) What does ‘delivering’ research entail?    
The range of responsibilities reported in this study are broadly consistent with those 
previously described in the UK (Bird & Kirshbaum, 2005; Gibbs & Lowton, 2012), Australia 
and New Zealand (Rickard et al, 2011; Wilkes et al, 2012), and other countries (Eastwood, 
2012; Nagel et al, 2010), though there are differences in details.  While assessing and 
consenting patients and collecting data are the ‘cornerstone of research’ (Eastwood et al, 
2012: 843), and were reported by the great majority of participants, this study also provides 
further evidence of the wide-ranging activities undertaken by those who deliver health 
research (Hill and MacArthur, 2006; Spilsbury et al, 2008; Stephens-Lloyd, 2004)   
 
In recent years, attention has turned from describing the range of activities undertaken in 
delivering research to identifying clusters of activities which may constitute potentially distinct 
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roles.  The core responsibilities identified in this study align with the five domains of activities 
that Wilkes et al (2012) suggested as a cluster concerned with the recruitment to and day to 
day running of clinical trials which could be distinguished from a cluster concerned with other 
activities.  In the USA, Bevans, Hastings, Wehrlen et al (2011) drew a similar distinction 
between the role of the research nurse co-ordinator (RNC), who was oriented to a specific 
study or PI and engaged in activities such as recruitment, informed consent, and preparing 
research data for analysis and that of the clinical research nurse (CRN), who focused on 
direct clinical and research care to individual patients. For most participants in the present 
study, the balance of their activities was similar to that of the RNC.  This contrasts with the 
findings of Bevans’ own study, where only 18% of the sample were classified as RNCs, and 
suggests differences in the ways that the research nurse workforce is deployed in the UK and 
in the USA.   
 
Only rarely did the responsibilities of study participants extend beyond those of recruitment to 
and day to day running of their studies to include activities such as analysing data, writing 
publications and developing new studies.  Previous studies (Eastwood, 2012; Hill & 
MacArthur, 2006; Rickard et al, 2006; Roberts et al, 2011; Wilkes et al, 2012) have reported 
similar findings.  Bevans et al (2011), for example, reported that none of the RNCs in their 
study contributed to study grant development and only a minority to presentations, 
publications or other dissemination activities.  Other authors, however, have suggested that 
the role of research nurses often extends more widely, to encompass ‘academic, financial, 
managerial and administrative boundaries’ (Stephens-Lloyd, 2004: 20).  Rickard, Williams, 
Ray-Barruel et al (2011), for example, reported that 54% of their participants identified 
preparing grant submissions as one of their responsibilities, Roberts et al (2011) that 30% 
carried out their own research studies and Wilkes et al (2012) that 30% had at least once 
been identified as a Principal or Co-Investigator.  Barthow et al (2015) suggested that 
‘research nurses should [emphasis added] be involved in all aspects of a study including 
inception, design, testing, fieldwork, analysis and interpretation, and dissemination of results.’  
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These differences in expectations of the nature and scope of responsibilities point to 
uncertainties around the identity of those who deliver research and their position within 
nursing and research.  Rickard et al (2006) reported that a large variation in job titles led to 
confusion as to how to differentiate between roles and Scott et al (2013) also noted that 
unclear role definitions complicated the identification clinical trials nurses and made estimates 
of the size of the workforce difficult.  While a distinction is commonly drawn between 
‘research nurses’ who deliver research and ‘nurse researchers’ who lead research of interest 
or concern to nurses (Johnson & Stevenson, 2010; Watmough, Flynn, Wright, & Fry, 2010), 
further distinctions may need to be drawn between different types of ‘research nurses’.  
Bevans et al (2011) distinguished between CRNs and RNCs; however, a further distinction 
could usefully be made between ‘research nurse co-ordinators’ who are employed to deliver 
studies on behalf of (potentially many) CIs commonly based elsewhere and ‘research nurse 
officers/fellows’ who are employed directly by the grant holders to work as a member of their 
research team. While specific responsibilities of both research nurse co-ordinators and 
research nurse officers/fellows may vary according to the studies they work on, differences in 
their relationship with those who lead the study are likely to give rise to differences in the 
nature of their involvement across the whole research process.   
 
(iv) Do their responsibilities vary across employment contexts?   
Compared to those who worked in either Other hospitals or the Community, those who 
worked in the University Hospital were more likely to engage in activities at the extremes of or 
outside the Research Delivery Pathway.  That is, they were significantly more likely to be 
involved in the very early stages of research, including the development of new studies and 
preparation of documents such as protocols and research ethics forms needed in applying for 
the required approvals, and in the later stages of research including contributing to 
publications.  The fact that they were more likely to be employed solely in research posts may 
have facilitated their ability to engage in these activities.  Also important, however, were the 
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opportunities afforded by a large, research active organisation with a regular flow of new 
research studies.  The University Hospital was well placed to offer continuous employment to 
those who delivered studies and support their integration into a clinical team which both 
provided clinical care and developed and led their own research.  The experience they 
gained and the working relationships they established in this context may contribute to longer 
term career development within research nursing and, for the minority who are so inclined, 
facilitate the transition from research nurse to nurse researcher (Watmough et al, 2010).    
 
Community sites employed the widest variety of research staff, with a lower proportion of 
nurses and a higher proportion of psychologists and of those without a degree.  This may be 
related to the significantly higher proportion of questionnaire based studies and the higher 
proportion of psychological and behaviour change studies carried out in community and 
primary care settings.  Compared with the University Hospital and Other hospitals, 
participants recruited from Community sites were significantly more likely to report taking a 
medical history and carrying out initial assessments or conducting a physical examination as 
among their responsibilities.  This may reflect the particular demands made on those who 
deliver research based in the Community where, as Barthow et al (2015) suggest, their 
isolation from an academic environment and often from the community or primary care team 
means that they must draw on their professional skills and make their own decisions.  This 
isolation may also account for the finding that participants recruited from Community sites 
were significantly less likely to manage other staff than those in either the University or Other 
hospitals. 
 
Strengths and Limitations: 
Major strengths of this study were the use of a clearly-defined sampling frame, a good 
response rate and a relatively large sample size.  The final sample size of 168 is considerably 
higher than those of previous studies with the exception of Bevans et al (2011) in the USA.  A 
further strength was the development and piloting of the questionnaire with research nurses 
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and AHPs in a different area, to ensure it was meaningful and acceptable to participants and 
covered what they considered important topics.   
 
Research nurses and others employed by the study NHS Trusts and primary care practices 
to deliver research but who were not funded through NIHR infrastructure facilities were 
excluded from this study as it was not possible to identify the relevant population.  This 
means it is not possible to generalise the findings to this wider population and nor to compare 
the two populations.  Others have reported similar constraints:  Wilkes et al (2012) noted that 
the Clinical Trials Nurses should be considered a hard to reach population as there is no 
national register nor professional organisation which could provide a comprehensive 
sampling frame and Rickard et al (2011: 168) reported that ‘the lack of organisational 
recording of research nurse positions made it impossible to determine a response rate'.   
 
Further limitations include the self-report format of the questionnaire, the difficulties that some 
had in using the survey platform, and the length of the questionnaire which meant that not all 
who started it completed the questionnaire.  The response rate from those employed in Other 
hospitals was lower than in the University Hospital and Community, and the proportion of 
missing data was higher, which limits the generalisability of the findings to similar hospital 
contexts.   
 
 
Conclusion   
This paper provides evidence from a multi-site study with a clear sampling frame and good 
response rate of the nature of the workforce that delivers translational and applied health 
research in England.  While the majority are nurses, there is greater diversity in the workforce 
than has previously been reported.  In the context of a growing shortage of nurses generally, 
and the high proportion of studies which do not involve a clinical intervention, the number of 
those from other professional backgrounds is likely to increase.   
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It also makes clear the diverse range of types of study delivered, with varying degrees of 
challenge and scope for initiative and expertise, and the wide range of settings in addition to 
the traditional hospital, which provide differing opportunities and demands.  This diversity also 
needs to be acknowledged in educational, training and career planning to sustain capacity for 
delivering translational and applied health research in the future.   
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